{"id":46734,"date":"2021-05-28T05:57:58","date_gmt":"2021-05-28T05:57:58","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=74207"},"modified":"2021-05-28T05:57:58","modified_gmt":"2021-05-28T05:57:58","slug":"viatris-signs-memorandum-of-understanding-with-the-defeat-ncd-partnership-at-the-united-nations-institute-for-training-and-research-unitar","status":"publish","type":"post","link":"https:\/\/jordannewsgazette.com\/viatris-signs-memorandum-of-understanding-with-the-defeat-ncd-partnership-at-the-united-nations-institute-for-training-and-research-unitar\/","title":{"rendered":"Viatris Signs Memorandum of Understanding with The Defeat NCD Partnership at the United Nations Institute for Training and Research (UNITAR)"},"content":{"rendered":"
\n
\n
\n

Reveals initial findings of the Viatris sponsored report at a high-level panel discussion <\/i><\/p>\n

GENEVA and DUBAI, United Arab Emirates, May 27, 2021 \/PRNewswire\/ —\u00a0Viatris Inc. (NASDAQ: VTRS) and The Defeat-NCD Partnership (DNCD) at The United Nations Institute for Training and Research (UNITAR) today signed a Memorandum of Understanding (MoU), focused on continuing cooperation and jointly utilising and leveraging their existing resources and facilities for programmes and initiatives aimed at addressing non-communicable diseases (NCDs) and their impacts on NCD patients as a result of COVID-19. This by focusing on enhancing care policies for prevention and treatment, particularly in assisting low- and middle-income countries to meet their UN Sustainable Development goals (SDG 3.4), to reduce NCD mortality by a third by 2030.<\/p>\n

“Collaboration with reputed private sector healthcare companies forms an integral part of the solution to address the challenges faced by NCD patients, especially in low resource settings. We welcome Viatris joining the Partnership’s efforts and supporting our mission globally,” said Mukul Bhola, Chief Executive Officer of The Defeat-NCD Partnership at UNITAR.<\/p>\n

\"Viatris<\/div>\n

This collaboration was announced as part of high-level panel discussion organised by The Defeat-NCD Partnership on “Uninterrupted Health Services for NCDs during the COVID-19 Crisis” on the margins of the 74th<\/sup> World Health Assembly, calling on governments to take action on ensuring uninterrupted NCD care during challenging times where political commitment is even more needed.<\/p>\n

The latest research report, which was led by The Economist Intelligence Unit (EIU) and co-authored by DNCD on the implications of NCD care policies on COVID-19 disease management, collating global data, shows positive correlation between NCD mortality rates and COVID-19 case fatalities. This was a study that Viatris was proud to support, while at the same time giving authors the autonomy they required.<\/p>\n

Menassie Taddese, President of Emerging Markets at Viatris, who joined the event shared some light on the research and what it means for Viatris, “With 85 percent of NCD deaths taking place in the 125 countries within our Emerging Markets region, our scientists, medical professionals and regulatory experts are hard at work reaching vulnerable communities so that they have access to vital healthcare. Viatris is among the leading healthcare companies to which citizens look to for treatment of NCDs and we will continue to invest and to push policy towards NCD and COVID care.”<\/p>\n

Other insights from the report include:<\/p>\n